Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
The model's full reasoning — Q4 2016 call → NOWe need answer only YES or NO. Need evaluate based on transcript. Need determine if management's account rests on several small concrete ground-level wins named individually AND management explicitly treats accumulating episodes as leading edge of broader improvement still early. We need parse transcript. Company Bristol-Myers Squibb Q4 2016. Management discusses Opdivo, Yervoy, Eliquis, etc. Need identify specific episodes from recent period. They mention: price negotiations completed for France and Germany in quarter, resulting $373 million revenue recognition including $250 million deferred. That's a specific event. Also mention head-and-neck launch, expected bladder approval (not yet happened). Also mention in Germany RCC uptake emerging. Also mention in France and Germany Opdivo business performing well in melanoma and lung. Also mention U.S. regained market share in RCC during Q4. Also mention Eliquis demand growth. Also mention hep C decline. Also mention IP settlement with Merck (positive resolution) - not operational episode. Also mention Sprycel patent appeal decision expected. Need see if at least three distinct named episodes from recent period that are ground-level wins. Management mentions: "Specifically in the quarter, we completed price negotiations for France and Germany." That's one. "In the U.S., we did see demand growth, although at a slowing rate... sales roughly flat vs Q3, including inventory work-down." Not episode. "strong execution in RCC, where we've regained market share during fourth quarter." That's an episode? Regained market share in RCC during Q4 - specific. "recent head-and-neck launch" - launched recently, but not necessarily episode in quarter? "potential bladder launch" future. "In Germany, we see the emergence of our RCC uptake where you can get rapid adoption prior to final price negotiations." That's an episode. "In France and Germany, Opdivo business performing well in melanoma and lung." Also "we completed price negotiations for France and Germany." Also "successful outcome of price negotiations in both France and Germany resulted in $373 million revenue recognition in quarter, inclusive of approximately $250 million deferred from previous quarters." That's a specific event.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
AU · Q2 2018 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple specific, recent operational episodes: Kibali’s underground ramp-up with automated ore handling system and vertical shaft integration; Iduapriem’s CIL tank conversion and grade/tonnage gains; Sunrise Dam’s Recovery Enhancement Project plus new mining strategies; Tropicana’s second 6-MW ball mill installation; Siguiri’s CIL circuit milestone; and 338 tracked Operational Excellence projects.
BXP · Q1 2022 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple distinct, named episodes from the recent period: the 73,000 sq ft recapture/release at 77 CityPoint with a 15% rent increase and 7.
CRGO · Q1 2024 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...